Standout Papers

The ferroptosis inducer e... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. The ferroptosis inducer erastin irreversibly inhibits system xc− and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells
    2018 306 citations Mami Sato, Ryosuke Kusumi et al. Scientific Reports profile →

Immediate Impact

1 by Nobel laureates 9 from Science/Nature 71 hit
Sub-graph 1 of 22

Citing Papers

Rational Design of Nanozymes for Engineered Cascade Catalytic Cancer Therapy
2025 Hit
Ironing out the role of ferroptosis in immunity
2024 Hit
1 intermediate paper

Works of T. Izumikawa being referenced

The ferroptosis inducer erastin irreversibly inhibits system xc− and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells
2018 Hit

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
T. Izumikawa 237 197 180 167 98 40 550
D. J. Brenner 158 0.7× 130 0.7× 218 1.2× 56 0.3× 135 1.4× 29 617
Taljit S. Sandhu 146 0.6× 71 0.4× 39 0.2× 58 0.3× 121 1.2× 29 566
R.R. Perry 49 0.2× 103 0.5× 28 0.2× 119 0.7× 110 1.1× 30 576
L. Tallone 171 0.7× 68 0.3× 30 0.2× 305 1.8× 106 1.1× 32 536
A. Hauptner 201 0.8× 149 0.8× 20 0.1× 40 0.2× 204 2.1× 24 564
Helmut Lindner 58 0.2× 65 0.3× 16 0.1× 156 0.9× 59 0.6× 42 483
Ekkehard Pomplun 196 0.8× 215 1.1× 35 0.2× 13 0.1× 121 1.2× 28 485
Y. Charon 115 0.5× 67 0.3× 35 0.2× 42 0.3× 257 2.6× 46 568
K. V. Pavlov 85 0.4× 183 0.9× 156 0.9× 86 0.5× 119 1.2× 36 554
T. Okuda 44 0.2× 92 0.5× 24 0.1× 229 1.4× 34 0.3× 64 578

All Works

Loading papers...

Rankless by CCL
2026